Latest Close
$21.18
News
SRPT
Sarepta Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to SRPT.
1y Change
-$29.85 (-58.50%)
Market Cap
$2.22B
Sector
Healthcare
Industry
Biotechnology
Recommendation
hold
Sarepta siRNA Data Adds New Pillar To Rare Disease Pipeline Narrative
Simply Wall St. • Apr 8, 2026
Read articleRBC Adjusts Price Target on Sarepta Therapeutics to $19 From $18, Maintains Sector Perform Rating
MT Newswires • Apr 7, 2026
Read articleHow The Sarepta Therapeutics (SRPT) Investment Story Is Shifting On Mixed Elevidys And Pipeline Views
Simply Wall St. • Apr 7, 2026
Read article5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
24/7 Wall St. • Apr 1, 2026
Read articleSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • Mar 31, 2026
Read articleMRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance
24/7 Wall St. • Mar 29, 2026
Read article